Cambridge Antibody Technology Group Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cambridge Antibody Technology Group

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (425)	11/18/2003 11:01:41 AM
From: nigel bates	of 625

Reading Chambre's reported comments in some of today's press, it seems that this thing is indeed the result of bad drafting, given that the original clause was there to protect Knoll from competing claims on phage IP. Abbott's position here stinks, and I hope they find real difficulty in striking deals in the future. CAT should win this, but without seeing the language of the relevant clause, I wouldn't like to make a firm prediction.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next